Anavex Life Sciences
AVXL
$3.44
Share price
1.47%
Change (1 day)
-57.74%
Change (1 year)
Categories
Anavex Life Sciences (AVXL) - Cash on Hand
Cash on Hand as of December 2023 : $0.14 B
According to Anavex Life Sciences
's latest financial reports the company has $0.14 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Anavex Life Sciences - Cash on Hand chart (from 2005 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-09-30 | $0.15 B | 1.25% |
| 2022-09-30 | $0.14 B | -1.94% |
| 2021-09-30 | $0.15 B | 420.04% |
| 2020-09-30 | $29.24 M | 31.84% |
| 2019-09-30 | $22.18 M | -3.25% |
| 2018-09-30 | $22.93 M | -16.43% |
| 2017-09-30 | $27.44 M | 198.69% |
| 2016-09-30 | $9.18 M | -39.92% |
| 2015-09-30 | $15.29 M | 110.56% |
| 2014-09-30 | $7.26 M | 2004.52% |
| 2013-09-30 | $0.34 M | 2937.09% |
| 2012-09-30 | $0.01 M | -91.57% |
| 2011-09-30 | $0.13 M | -49.11% |
| 2010-09-30 | $0.26 M | -24.59% |
| 2009-09-30 | $0.35 M | 5421.38% |
| 2008-09-30 | $0 M | 25328% |
| 2007-09-30 | $0 M | -99.8% |
| 2006-09-30 | $0.01 M | 1156.4% |
| 2005-09-30 | $0 M | -96.52% |
| 2004-09-30 | $0.02 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Ligand Pharmaceuticals LGND | $0.17 B | 18.46% | 🇺🇸 USA |
 Corcept Therapeutics
CORT | $0.36 B | 156.13% | 🇺🇸 USA |
 Palatin Technologies PTN | $9.48 M | -93.40% | 🇺🇸 USA |
 BioCryst Pharmaceuticals
BCRX | $0.38 B | 170.57% | 🇺🇸 USA |